Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPICILLIN vs AMPRENAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMPICILLIN vs AMPRENAVIR: Safety Overview

Metric AMPICILLIN AMPRENAVIR
Total FAERS Reports 3,653 109
Deaths Reported 482 4
Death Rate 13.2% 3.7%
Hospitalizations 1,227 16
Average Patient Age 45.1 yrs 44.0 yrs
% Female Patients 65.6% 25.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 15, 1999
Manufacturer Meitheal Pharmaceuticals Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Discontinued